Articles related to MYASTHENIA GRAVIS
Telehealth Referral Leads to Diagnosis and Effective Treatment of Rare Neuropathy: Case Study
This case study exemplifies the significant impact of telehealth and multidisciplinary collaboration in diagnosing and treating complex cases of neuropathy, highlighting the importance of specialized testing in uncovering precise diagnoses and guiding effective treatments.
Endocrinology, Diabetes, Metabolism January 29th 2024
FDA Approves Zilbrysq as First Once-Daily Subcutaneous C5 Inhibitor for Generalized Myasthenia Gravis
The approval of Zilbrysq marks a significant advancement in the treatment landscape for generalized myasthenia gravis. With its unique mechanism of action and self-administration, it offers a promising new option for patients.
Neurology October 24th 2023
What are the Treatment Options for Myasthenia Gravis if First-line Agents Fail?
Consider immunosuppressive therapy in patients on adequate acetylcholinesterase inhibitor therapy who do not demonstrate significant benefit. This article discusses the assessment of therapeutic failure, steroidal therapy, when to consider nonsteroidal anti-inflammatory therapy, and recommendations for monitoring treatment.
Neurology February 28th 2023
Complement and the Prothrombotic State
Parallels and distinct features among paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are discussed against the background of thrombosis, complement activation via eculizumab, and potential complement diagnostic and therapeutic avenues.
Hematology April 5th 2022